08th week of 2011 patent applcation highlights part 39 |
Patent application number | Title | Published |
20110045030 | CROSSLINKABLE POLYISOBUTYLENE-BASED POLYMERS AND MEDICAL DEVICES CONTAINING THE SAME - The present invention pertains to crosslinkable and crosslinked polyisobutylene-based polymers, to compositions that contain such polymers, and to medical devices that are formed using such polymers. According to one aspect, the present invention pertains to crosslinkable and crosslinked compositions that comprise a copolymer that comprises a polyisobutylene segment and two or more reactive groups. According to another aspect, the present invention pertains to medical devices that contain such compositions. According to another aspect, the present invention pertains to methods of making medical devices using such compositions. | 2011-02-24 |
20110045031 | Use of Buckysome or Carbon Nanotube for Drug Delivery - Compositions and methods for administering a therapeutic agent to a mammal are disclosed. The compositions comprise either (i) vesicles comprising an amphiphilic substituted fullerene, wherein the therapeutic agent is present in the vesicle interior or between layers of the vesicle wall, (ii) a substituted fullerene, comprising a fullerene core and a functional moiety, wherein the therapeutic agent is associated with the substituted fullerene, or (iii) carbon nanotubes, wherein the therapeutic agent is covalently bonded to the carbon nanotubes. | 2011-02-24 |
20110045032 | COMPOSITION, FORMULATIONS & KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH DEHYDROEPIANDROSTERONE(S) STEROID & AN ANTI-MUSCARINIC AGENT(S) - A pharmaceutical or veterinary composition comprises a non-corticosteroids, and/or salts thereof, and an anti-muscarinic (anti-cholinergic) agent, and/or pharmaceutically or veterinarily acceptable salts thereof. The composition is provided in various formulations and in the form of a kit. The products of this patent are useful in the prophylaxis and treatment of various respiratory, lung and malignant diseases. | 2011-02-24 |
20110045033 | Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders - The invention relates to the combination of the cholecystokinin-2 (CCK-2) receptor antagonist Itriglumide and proton pump inhibitors (PPIs) for the treatment of patients suffering from gastrointestinal and related disorders. | 2011-02-24 |
20110045034 | Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use - The invention relates to an improved dry cross-linked gelatin sponge comprising a layer of an active ingredient, to methods of its preparation and uses thereof. | 2011-02-24 |
20110045035 | METHODS OF TREATING OPHTHALMIC DISORDERS - Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude | 2011-02-24 |
20110045036 | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle - Topical cosmetic use as a whitening active ingredient of at least one peptide, comprising at least one blocked aromatic cycle and having the general formula (I): A-(Xa)m-Xc-(Xb)n-B. The invention also discloses a cosmetic composition comprising at least said peptide and a method of decreasing skin pigmentation, whitening or lightening human skin, comprising a topical application of said composition. | 2011-02-24 |
20110045037 | FOAM CONTAINING BENZOYL PEROXIDE - The present invention relates to foamable compositions for treating acne comprising benzoyl peroxide; to a therapeutic kit comprising such compositions; and to a method of treating acne using such compositions. | 2011-02-24 |
20110045038 | METHOD OF MAKING COMPOSITIONS COMPRISING MULTIPLE LAYERS - A method of making a personal care composition comprising the steps of: (a) providing a first layer and a second layer which each are fluid at elevated temperature; solid at ambient temperature; and visually distinctive from each other; (b) providing the first and second layers in fluid state at an elevated temperature in isolated vessels; (c) separately dispensing the first layer by a first nozzle and the second layer by a second nozzle, while maintaining the elevated temperature, into a same package having a circle plan view shape; (d) wherein the positions of the nozzles, relative to the center of the package, are maintained during dispensing, wherein the middle point of the nozzles do not coincide with the Z axis running vertically through the center of the package; and (e) cooling the dispensed composition for solidifying in the package. | 2011-02-24 |
20110045039 | Hair Care Compositions Comprising First and Second Sucrose Polyesters - A hair care composition comprising: a) at least one first sucrose polyester has a melting point of above 30° C. and an iodine value (IV) of from 0 to 70; b) at least one second sucrose polyester has a melting point of 30° C. or less and an iodine value (IV) of from above 70 to about 180; and c) an aqueous carrier, for delivering conditioning benefits especially friction reduction on dry hair. | 2011-02-24 |
20110045040 | FACE MASK - A face mask that has tab parts at opposing positions approximately on an upper side of the face shape, and a ridge-folded part and a valley-folded part are alternately folded in a lateral direction of the face and further folded perpendicularly to these folding lines, where the tab parts are folded in a manner projecting outward, so that the face mask having such fold structures can easily be spread out. | 2011-02-24 |
20110045041 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF AGENTS - The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein. | 2011-02-24 |
20110045042 | PRESERVATIVE MATERIAL AND STORAGE METHOD FOR LIQUID - A nanofiber structure having pores is used as a preservative material for a liquid material. A liquid material can be stored for a long period without causing deterioration and without the need of using any additive such as an anti-bacterial agent merely by contacting the liquid material with the preservative material. | 2011-02-24 |
20110045043 | SUSTAINED RELEASE MICROBIAL INSECT CONTROL COMPOSITION AND MEANS - Effective sustained release of microbial pesticides in aquatic environments can be achieved by the combination of buoyant particles with a particulate microbial active ingredient. The resulting materials in the form of a particulate have combined density of less than one. The materials are then dispersed into gypsum slurry that is poured into briquette molds, or made into granules or pellets of various sizes, to form a solid, sinking, pest control composition. Once applied in aquatic field sites, the surface of the matrix slowly dissolves, releasing many minute buoyant pesticide laden particles to the water surface over the life of the product. Once at the surface, the particulate microbial pesticide(s) release from the buoyant particles and are distributed throughout the water column to be ingested by susceptible immature filter feeding mosquitoes and pestiferous flies. | 2011-02-24 |
20110045044 | COMPOSITIONS FOR REPAIR OF DEFECTS IN TISSUES, AND METHODS OF MAKING THE SAME - Tissue repair compositions, particularly bone repair compositions, containing (a) bone fragments and (b) homogenized connective tissue, and methods for making the same are provided. Some of the inventive tissue repair compositions contain a radioprotectant. The compositions can be used in the form of an injectable gel, an injectable paste, a paste, a putty, or a rehydratable freeze-dried form. Kits for using such tissue repair compositions are also provided. | 2011-02-24 |
20110045045 | Production of and uses for decellularized lung tissue - The present invention provides a process of producing a decellularized extracellular matrix DC lung from native lung tissue using rapid freeze/thaw cycling to induce cellular damage and the constant circulation of a detergent or peracetic acid and enzymatic digestion with DNAase/RNAase within a continuously rotating bioreactor. Also, provided are methods to produce a functional engineered lung tissue on the DC lung using endogenous lung progenitor cells. In addition, a composition comprising the DC lung and the endogenous lung progenitor cells seeded therein or thereon and an implantable composition comprising the functional engineered lung tissue which are useful in methods of treating a lung to restore at least some function thereto. | 2011-02-24 |
20110045046 | GLYCOPEPTIDES AND METHODS OF MAKING AND USING THEM - In one embodiment, the invention provides glycopeptides (or carbohydrate-peptide conjugates) comprising TACAs that direct against (e.g., bind specifically to) cytotoxic T lymphocytes (CTLs) or helper T cells for, e.g., CTL- or T-helper-based immunotherapy of carcinomas, and methods for making and using the glycopeptides of the invention. In one embodiment, the invention provides novel glycopeptides comprising tumor-derived carbohydrate or tumor-derived epitopes that specifically bind to major histocompatibility (MHC) class I molecules on cytotoxic T lymphocytes (CTLs) or MHC molecules on helper T cells, and methods for using same, e.g., as a vaccine, including a pan-cancer vaccine. | 2011-02-24 |
20110045047 | HEMOSTATIC IMPLANT - The present disclosure relates to collagen-containing implants including a porous substrate having a first hydrogel precursor and a second hydrogel precursor applied thereto in a manner such that the first hydrogel precursor and second hydrogel precursor do not react with each other until the implant is placed at the site of implantation and exposed to the physiological fluids of a patient. | 2011-02-24 |
20110045048 | BONE GRAFT AND SCAFFOLDING MATERIALS IMMOBILIZED WITH TYPE I COLLAGEN BINDING PEPTIDES - The present invention relates to a pharmaceutical composition comprising a bone graft material, a scaffold for tissue engineering applications and type I collagen Binding Peptides which have bone calcification-promoting peptides immobilized on the surface, and more particularly, to a bone graft material and a scaffold for tissue engineering applications (hereinafter, referred to as scaffold), which have peptides specifically binding with type I collagen immobilized on the surface, and pharmaceutical composition for recovering tissue regeneration containing type I collagen binding-inducing peptide. In the inventive bone graft material and scaffold for tissue engineering applications, the cells related to regeneration by collagen binding-inducing peptide adhered to the surface, promote an adhesion of type I collagen binding-inducing peptide (main ingredients of extracellular matrix) to increase differentiation rate into bone tissues, and promote a calcification which is last step of bone regeneration to maximize a tissue regeneration finally. | 2011-02-24 |
20110045049 | IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE - This invention is directed to β-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The β-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety. | 2011-02-24 |
20110045050 | NANOEMULSION FORMULATIONS FOR DIRECT DELIVERY - A nanoemulsion and corresponding methods of making and using systems of single or blended high HLB value surfactant(s) for the emulsification of single or blended oils and vitamin E components in an aqueous phase are provided. The resulting nanoemulsions and methods of administering the nanoemulsions, including a corresponding kit, provide delivery of the nanoemulsions to a patient. | 2011-02-24 |
20110045051 | EXTRACELLULAR MATRIX COMPRISING PLATELET FACTORS - The present invention describes an extracellular matrix comprising human platelet derived growth factors, that permits the maximising of therapeutic efficacy, combining the benefits of both components, to result in a more efficient and rapid integration of the matrix up to the structurally organised reconstruction of the neoformed tissue “in vivo” | 2011-02-24 |
20110045052 | Bioactive Glass Coatings - The present invention relates to bioactive glass coatings. In particular, the present invention relates to bioactive glass coatings for Ti6Al4V alloys and chrome cobalt alloys, wherein the thermal expansion coefficient of the glass coating is matched to that of the alloy. Such coatings have a particular application in the field of medical prosthetics. The bioactive glass comprises (in mol %) 35-53 SiO2; 2-11 Na20; at least 2% of each of CaO, MgO and K20; 0-15 ZnO; 0-2 B202 and 0-9 P205. | 2011-02-24 |
20110045053 | ISOLATED POPULATION OF LUMINAL STEM CELLS THAT GIVE RISE TO PROSTATE CANCER AND METHODS OF USING SAME - The present invention is directed to an isolated population of luminal stem cells obtained from the prostate epithelium that express Nkx3.1. The invention is also directed to methods for diagnosing whether a patient is at risk of developing prostate cancer. | 2011-02-24 |
20110045054 | MATERIALS AND METHODS FOR TREATING AND MANAGING PLAQUE DISEASE - Disclosed herein are materials and methods suitable for treating and managing plaque disease, including vulnerable plaque. An implantable material comprising cells, such as but not limited to endothelial cells, and a biocompatible matrix can reduce progression or deterioration of a plaque-associated lesion situated on the interior lumen of said blood vessel. The implantable material is implanted directly on an exterior surface of a blood vessel at or adjacent or in the vicinity of the site of a lesion on an interior lumen. Alternatively, the implantable material is deposited on an exterior surface at or adjacent or in the vicinity of the site of a lesion on an interior lumen by an intraluminal delivery device which traverses or penetrates the vessel wall or by a percutaneous delivery device which enters the perivascular space. Both modes of administration can be preceded by or coincident with an imaging step. The present invention can treat hemorrhage, erosion, fissure, plaque-associated thrombosis and occlusion, rupture, displacement and/or dislodgement of a plaque lesion. | 2011-02-24 |
20110045055 | MEDICAL DEVICES CONTAINING THERAPEUTIC AGENTS - According to one aspect of the invention, implantable or insertable medical devices are provided which can delay release of one or more therapeutic agents for a predetermined time after implantation in a subject. In various embodiments, a therapeutic agent delivery profile of this type is provided by employing a temporary barrier layer which initially permits little to no release of the therapeutic agent, but which layer permits much greater release levels after a predetermined period of time. Other aspects of the invention relate to methods of forming such devices and to methods of using such devices. | 2011-02-24 |
20110045056 | HYDROGEL CO-POLYMER COMPOSITION AND ITS USES, FOR EXAMPLE AS A WOUND DRESSING - The present invention provides a hydrogel composition, preferably for the treatment of wounds, comprising a hydrophilic co-polymer carrying multiple pendant anionic groups, wherein the polymer is derived from a first monomer and a second monomer, wherein both monomers have an octanohwater partition coefficient Log P value of less than 0, and, the Log P value of the first monomer is greater (more positive) than the second monomer. Preferably the difference between the Log P value for the two monomers is at least 0.1, preferably at least 0.2. The difference between the Log P value for the two monomers is preferably less than 2. The weight ratio (w/w) of the first monomer/second monomer in the hydrogel composition is preferably equal to or more than about 1. The pendant anionic groups may be sulphonyl groups, e.g. sulphonic acid groups or salts thereof. The anionic group in both first and second monomers may be in salt form and the counterion for both monomers is preferably the same. | 2011-02-24 |
20110045057 | Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof - The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same. | 2011-02-24 |
20110045058 | TRANSFECTION REAGENT - The invention described herein features methods, compositions, and kits for introducing a nucleic acid molecule or biologically active molecule into a eukaryotic cell in vitro or in vivo utilizing a reagent containing energy-rich additives. | 2011-02-24 |
20110045059 | VACCINE AGAINST VARICELLA ZOSTER VIRUS - Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL are also claimed | 2011-02-24 |
20110045060 | KIT FOR DETECTING CANCER CELLS METASTASIZING INTO SENTINEL LYMPH NODE - A kit for detecting cancer cells metastasizing into a sentinel lymph node which comprises a human lymph channel-origin endothelial cell line attached to a base material. A drug delivery agent toward to sentinel lymph node wherein an antibody against an adhesive molecule, which mediates the adhesion of metastatic cancer cells from a primary cancer lesion to lymph channel endothelial cells in the sentinel lymph node, is exposed on the surface of colloidal particles. | 2011-02-24 |
20110045061 | GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE - It is possible to stimulate the angiogenesis of an ischemic site declined by diabetes and to recuperate ischemic disease by administering HGF (hepatocyte growth factor) gene to the diabetic ischemic. | 2011-02-24 |
20110045062 | FORMULATION - This invention relates to a formulation comprising a dipeptidylpeptidase IV (DPP-IV) inhibitor preferably vildagliptin and metformin, to tablets comprising such formulations and to processes for the preparation thereof. | 2011-02-24 |
20110045063 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF - The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts. | 2011-02-24 |
20110045064 | FORMULATIONS OF 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE - Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease. | 2011-02-24 |
20110045065 | SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to medicinal formulations having anti-oxidant, geroprotective and anti-ischemic activity. Said formulations include 3-hydroxy 2,4,6 trimethylpyridine, pharmaceutically acceptable salts, esters, derivatives and polymorphs thereof. | 2011-02-24 |
20110045066 | Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus - The present invention refers to a new compound containing Silymarin with Carbopol for the treatment of Diabetes Mellitus. This compound morphologically and structurally regenerates the damage that occurs in the pancreatic tissue in Diabetes Mellitus, and regenerates the insulin-producing pancreatic cells (β cells). It therefore regulates the serum levels of this hormone. Furthermore, it restores and maintains the normal concentrations of the blood glucose. | 2011-02-24 |
20110045067 | SOFT GEL CAPSULES - The invention relates to soft gelatin capsules containing at least one pharmaceutical, wherein the capsule shell includes carrageenan and cold water fish gelatin or a mixture of cold fish gelatin and warm fish gelatin. | 2011-02-24 |
20110045068 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL ADMINISTRATION OF PPI - The present invention relates to pharmaceutical formulations comprising a layer of compressed granules to facilitate the administration of oral PPI. | 2011-02-24 |
20110045069 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE - A description is given of precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease, in particular for the prevention or treatment of Type 2 diabetes. | 2011-02-24 |
20110045070 | COMBINATION THERAPY - The present invention provides a composition comprising zinc and trimethoprim, particularly in a weight ration of about 1:3 to about 1:7, as well as a sustained- or prolonged-release preparation which comprises trimethoprim and zinc and a biodegradable polymer providing a clinically useful composition which has prolonged release over a long period of time. | 2011-02-24 |
20110045071 | GENERATION OF A NOVEL TYPE OF ANTI-INFLAMMATORY MACROPHAGES FOR CLINICAL USE - The invention relates to a purified, novel anti-inflammatory population of macrophage and methods of making and using such macrophage. | 2011-02-24 |
20110045072 | PHARMACEUTICAL COMPOSITION, DRESSING AND METHOD FOR TREATING SKIN LESION, INTERMEDIATE COMPOSITION AND PROCESS FOR PREPARING SAID DRESSING, AND USE OF CERIUM SALT ASSOCIATED WITH A COLLAGEN MATRIX - The present invention refers to a pharmaceutical composition for treating skin lesion, comprising a cerium salt on a collagen matrix and a dermatologically acceptable carrier. In addition, the present invention also provides an intermediate composition for preparing a dressing for treating skin lesion and a process for preparing such dressing by lyophilizing said intermediate composition. The present invention also refers to a dressing for treating skin lesion, comprising a cerium salt on a collagen matrix, as well as to the use of a cerium salt associated with collagen in the preparation of the pharmaceutical composition or dressing according to the present invention. Another embodiment of the present invention is a method for treating skin lesion by applying such pharmaceutical composition or dressing on said skin lesion. The composition or dressing of the present invention can be used in topical applications in a variety of lesion types, such as skin lesions involving the release of toxins related to microbial proteins on human or animal organisms, or those so-called HSPs (heat shock proteins); burns which involve burned skin toxin formation or LPC (lipoprotein complex); chronically ulcerate skin lesions in which there is an overproduction of proteinase; skin lesions of difficult resolution, in which control of exudate overproduction is required; and critically infected or colonized skin lesions. | 2011-02-24 |
20110045073 | METHODS AND COMPOSITIONS OF SPHINGOLIPID FOR PREVENTING AND TREATING MICROBIAL INFECTIONS - The present invention relates to controlled release composition for preventing and/or treating microbial infections in the oral cavity of a subject, said composition comprising a controlled delivery matrix which matrix has releasably associated therewith an amount of between 0.000009 and 5 wt % of a sphingolipid, wherein the composition provides a sphingolipid-release-profile in the oral cavity of a subject, wherein said release-profile is maintained for between 15 seconds and 24 hours and wherein said release-profile provides for a concentration of said sphingolipid in the saliva of said subject of between 20 μmole/L and 250 μmole/L. | 2011-02-24 |
20110045074 | MATRIX TYPE SUSTAINED-RELEASE PREPARATION CONTAINING BASIC DRUG OR SALT THEREOF AND, METHOD FOR MANUFACTURING THE SAME - A matrix type sustained-release preparation and a manufacturing method therefor are provided wherein dissolution with low pH dependence of a basic drug or a salt thereof at the early stage of dissolution can be ensured in a dissolution test, and wherein as the dissolution test proceeds, a ratio of a dissolution rate of the basic drug or the salt thereof in an acidic test solution to a dissolution rate of the basic drug or the salt thereof in a neutral test solution (dissolution rate in the acidic test solution/dissolution rate in the neutral test solution) decreases with dissolution time at the late stage of dissolution, as compared to the early stage of dissolution. According to the present invention, the matrix type sustained-release preparation contains a basic drug or a salt thereof and at least one enteric polymer, in which solubility of the basic drug or the salt thereof in a 0.1 N hydrochloric acid solution and a neutral aqueous solution, pH 6.0 is higher than in a basic aqueous solution, pH 8.0. | 2011-02-24 |
20110045075 | TISSUE COATING FOR PREVENTING UNDESIRED TISSUE-TO-TISSUE ADHESIONS - Disclosed herein are a kit and a method for forming a tissue coating that prevents undesired tissue-to-tissue adhesions resulting from trauma, surgery, infection, or other stimulus. The tissue coating is a hydrogel formed by reacting an aminocarboxymethyldextran containing primary amine groups with an oxidized carboxymethylcellulose containing aldehyde groups. | 2011-02-24 |
20110045076 | LINEAR ORDER RELEASE POLYMER - Intravaginal drug delivery devices, including intravaginal rings, are provided herein. The devices comprise a polyether urethane composition and a pharmaceutically effective amount of at least one vaginally administrable drug homogeneously distributed throughout the polyether urethane. The devices are capable of exhibiting a substantially zero order release profile of drug over extended periods of time. Also disclosed are methods for making the devices and methods of using the devices to prevent or treat a biological condition. | 2011-02-24 |
20110045077 | ENCAPSULATED PANCREATIC ISLET CELL PRODUCTS AND METHODS OF USE THEREOF - This invention is directed, inter alia, to encapsulated cell products, compositions comprising the same and uses thereof to treat diabetes, and related complications, increase islet cell masses, improve a metabolic profile in a subject, and other related conditions. Processes to produce the encapsulated islet cell product are described. | 2011-02-24 |
20110045078 | PROCESS FOR PRODUCING CELLULOSIC SHAPED ARTICLES, CELLULOSIC SHAPED ARTICLES AND THE USE THEREOF - The invention relates to a process for producing cellulosic shaped articles with stabilized inclusions in a microfine dispersion of nonpolar organic compounds and mixtures by a dry-wet extrusion process. The shaped articles produced in this way exhibit by comparison with unmodified cellulose fibers a substantially increased storage capacity for heat and/or nonpolar active substances. They are suitable in particular for use in textiles for clothing, industrial textiles, leisure, medicine and cosmetics. Potential functional effects imparted include the physical effect of heat storage and/or the uniform and finely meterable storage and release of nonpolar active substances and plant extracts from the interior of the fibers of the shaped articles. It is possible through a suitable choice of the nonpolar portion to produce by this process also fibers capable of absorbing liquid or gaseous nonpolar substances. | 2011-02-24 |
20110045079 | DRY POWDERS OF CELLULAR MATERIAL - Methods and compositions of spray drying cellular material are provided that allow preservation of the cellular material. In one aspect, the cellular material is spray dried with a quantity of excipient. In another aspect, the cellular material is spray dried using a cryoprotectant. | 2011-02-24 |
20110045080 | Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto - The present invention includes single-walled carbon nanotube compositions for the delivery of siRNA and methods of making such single-walled carbon nanotube compositions. A single-walled carbon nanotube composition for delivery of siRNA includes a nonfunctionalized single-walled carbon nanotube; and siRNA noncovalently complexed with the nonfunctionalized single-walled carbon nanotube, wherein the siRNA solubilizes such nonfunctionalized single-walled carbon nanotube. | 2011-02-24 |
20110045081 | MAGNETIC, PARAMAGNETIC AND/OR SUPERPARAMAGNETIC NANOPARTICLES - The present invention relates to nanoparticles having a mean diameter of <500 nm and comprising, at their surface, a selected material. The nanoparticles are taken up by cells under physiological conditions and can be used to isolate interaction partners of the selected material within the cells. The present invention provides important advantages in that it opens up new ways of identifying cellular components and of delivering a substance of interest specifically to a selected cell compartment. The nanoparticles are also useful as a tool of diagnosis and for the constitution of chemical libraries. | 2011-02-24 |
20110045082 | AGGLOMERATES BY CRYSTALLISATION - The present invention describes novel agglomerates in crystalline form of β-lactum compounds, Furthermore, a process for the preparation of said agglomerates, wherein a solution or suspension of at least one β-lactum compound in a solvent is mixed with one or more anti-solvents has been described. | 2011-02-24 |
20110045083 | USE LARCH WOOD FOR TREATING INFLAMMATION - The application of raw wood material from a tree of the genus | 2011-02-24 |
20110045084 | LIGHT-CURABLE BONE GROWTH MATERIAL FOR TREATING DENTAL BONE DEFECTS - Improved compositions comprising a mixture of particulate bone growth material and polymeric carrier are provided. The particulate is preferably porous, resorbable, anorganic bone material. The polymeric carrier can be light-cured to form a cross-linked, biodegradable hydrogel. In one version, the bone growth material is a synthetic peptide bound to anorganic bone matrix particles and the carrier is methacrylated sodium hyaluronate (MHy) or methacrylated hydroxyethylcellulose (MHEC). The composition is particularly suitable for repairing defective dental and orthopedic bone tissue. The particulate and hydrogel carrier are biodegradable so the composition can be replaced by new bone formation over time. | 2011-02-24 |
20110045085 | PROCESS FOR OBTAINING POWDER COMPOSITIONS OF ORLISTAT - The invention relates to a novel process for the manufacture of stable, meeting relevant quality requirements pharmaceutical compositions in the form of encapsulated powder comprising Orlistat and pharmaceutically acceptable additives. The invention further relates to pharmaceutical compositions of Orlistat in the form of encapsulated powder obtained in accordance with the process of the present invention. | 2011-02-24 |
20110045086 | Steroid Nebuliser Formulation - A nebulizer formulation comprises particles of size 0.5-3 microns obtained by crystallization of beclomethasone diproprionate monohydrate in the presence of ultrasound. | 2011-02-24 |
20110045087 | POROUS BIOCOMPATIBLE POLYMER MATERIAL AND METHODS - Embodiments described include devices and methods for forming a porous polymer material. Devices disclosed and formed using the methods described include a spacer for spinal fusion, craniomaxillofacial (CMF) structures, and other structures for tissue implants. | 2011-02-24 |
20110045088 | INTRANASAL GRANISETRON AND NASAL APPLICATOR - Formulations and methods of manufacture are provided for granisetron dry powder compositions suitable for intranasal administration. Also provided are methods of use for preventing or controlling emesis and other diseases and disorders and devices, compositions, and methods for nasal delivery of therapeutic formulations. Devices for delivery of dry powder formulations are also provided. Devices can be single-use devices. | 2011-02-24 |
20110045089 | VITAMIN K3 DERIVATIVE / NSA FORMULATION - The present invention discloses highly stabilized nicotinamide (NA) formulated vitamin K3 derivative particles, whereby the NA forms a physical protective layer (both continuous and discontinuous) leading to highly stabilized vitamin K3 derivative particles, as well as a process for their production. | 2011-02-24 |
20110045090 | FORMULATIONS OF FLIBANSERIN - The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin. | 2011-02-24 |
20110045091 | ANTI-ANGIOGENESIS, ANTICANCER PROLIFERATION PROPERTIES OF LYMPHOCYTIC-DERIVED MICROPARTICLES - Recent studies have demonstrated that lymphocyte-derived microparticles (LMPs) impair endothelial cell function. The present invention concerns the use of LMPs in the regulation of angiogenesis or diseases such as cancer or retinopathy of prematurity (ROP). Having long been considered as cellular debris, microparticles constitute reliable markers of vascular damage. Released into biological fluids, microparticles are involved in the modulation of key functions including immunity, inflammation, vascular remodeling and angiogenesis. The present data demonstrates that LMPs have considerable impact on angiogenesis in vitro and in vivo. In view of this, LMPs may be important contributors to the pathogenesis of diseases that are accompanied by impaired angiogenesis and could thus influence vascular function (microvascular angiogenesis and vasopermeability of ischemic tissue, alerting the body for special attention and the need for emergency repair procedures. | 2011-02-24 |
20110045092 | CASEIN PARTICLES ENCAPSULATING THERAPEUTICALLY ACTIVE AGENTS AND USES THEREOF - Casein particles, such as micelles or clusters thereof, having encapsulated therein hydrophobic and/or water insoluble therapeutically active agents such as hydrophobic chemotherapeutic agents, which are otherwise administered parenterally, are disclosed. Pharmaceutical compositions containing the casein particles and uses thereof in the treatment of cancer and other conditions treatable by the encapsulated therapeutically active agent are also disclosed. Further disclosed are processes of preparing the casein particles. The disclosed casein particles are useful for orally delivering the therapeutically active encapsulate and can further be used for controllably releasing the agents in the gastrointestinal tract. | 2011-02-24 |
20110045093 | PHARMACEUTICAL COMPOSITION AND PROCESS COMPRISING VEGETABLE PROTEOLYTIC ENZYMES IN SUPRAMOLECULAR NANOPARTICLES, FOR THE TREATMENT OF PEYRONIE'S DISEASE, CONNECTIVE TISSUE DISEASES AND USE - This invention refers to a pharmaceutical composition applied to the therapy of Peyronie's disease, in connective tissue diseases. The composition comprises, in its formulation, vegetable proteolytic enzymes encapsulated in the supramolecular nanoparticles. | 2011-02-24 |
20110045094 | ENCAPSULATED QUANTUM DOT - A particle comprising a quantum dot encapsulated by an amphiphilic polymer. These particles are suitable for use in biological and biomedical research and may emit fluorescence and may be water-soluble and biocompatible. The encapsulated quantum dot may be introduced into a living system without any substantial toxic or immunological effects. | 2011-02-24 |
20110045095 | POLYMER-PHOSPHOLIPID SHELLED MICROBUBBLES - A multiple layer microfluidic system and multiple layer microbubble are disclosed. The microfluidic system for producing multiple layer microbubbles includes a first inlet which receives a gas and directs the gas into a central stream, a second inlet which receives an oil and flow focuses the oil around the gas, a third inlet which receives a polymer and lipid solution and flow focuses the polymer and lipid solution around the oil and a fourth inlet which receives a surfactant solution and flow focuses the surfactant solution around the polymer and lipid solution. The multiple layer microbubble includes a gas core, a polymer and lipid shell surrounding the gas core and a surfactant layer surrounding shell. | 2011-02-24 |
20110045096 | Solubilized delivery system for topical anesthetics - A nano particle drug delivery system comprised of micelles coated with lipid molecules for the non-invasive deployment and absorption of active anesthetic compounds through the stratum corneum and throughout the skin and sub cutaneous tissue without any cutaneous toxicity. | 2011-02-24 |
20110045097 | SOLID PHARMACEUTICAL COMPOSITION COMPRISING IRBESARTAN - The present invention concerns preferably surfactant-free solid pharmaceutical formulations comprising, as an active ingredient, at least one of irbesartan and pharmaceutically acceptable salts thereof, and at least one disintegrant. Preferably, the active ingredient comprises irbesartan hydrochloride. | 2011-02-24 |
20110045098 | EXCITATORY GLYCINE RECEPTORS AND METHODS - The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods. | 2011-02-24 |
20110045099 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE - A method of modulating inflammation in an organism, which includes administering to an organism a composition including a therapeutic amount of an extract from the plant | 2011-02-24 |
20110045100 | Antimalarial Quinolines and Methods of Use Thereof - One aspect of the invention relates to substitute quinolines with antimalarial activity, and compositions and kits comprising at least one of them. Another aspect of the invention relates to methods for the treatment or prevention or both of malaria comprising administering to a subject a therapeutically effective amount of such a compound. Importantly, a number of the compounds show excellent potency against both chloroquine-sensitive and chloroquine-resistant strains. | 2011-02-24 |
20110045101 | FUNGICIDAL SUBSTITUTED AZOLES - Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, | 2011-02-24 |
20110045102 | Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide - The present invention provides compositions and methods for inhibiting growth of and/or killing cancer cells. The compositions include: an inhibitor of the PI3K signal transduction pathway, and additional agents, such as Triptolide. | 2011-02-24 |
20110045103 | METHODS FOR TREATING AIDS - The present invention pertains to methods of inactivating human immunodeficiency virus (HIV), both in vitro and in vivo. Such methods also relate to treating HIV-related symptoms and the treatment of acquired immune deficiency syndrome in patients. Methods typically employ administering a composition comprising ammonium chloride such that HIV is inactivated. | 2011-02-24 |
20110045104 | 3-[1-(3-Haloalkyl)triazolyl]phenyl sulphide derivatives as acaricides and insecticides - The present invention constitutes new 3-[1-(3-haloalkyl)triazolyl]phenyl sulphide derivatives of the formula (I) | 2011-02-24 |
20110045105 | COSMETIC USE OF AN OPHIOPOGON JAPONICUS ACTIVE PRINCIPLE - The use of at least one extract that is obtained from | 2011-02-24 |
20110045106 | COFFEE EXTRACT - The present invention relates to a method of producing a coffee extract with antioxidant and anti-inflammatory properties and uses of the extract of the invention. The coffee extract comprises caffeic acid and/or ferulic acid and can be produced by hydrolysing chlorogenic acids present in coffee extract, e.g. with a microorganism or an enzyme. The coffee extract of the invention may e.g. be used as an ingredient of a food or beverage product. | 2011-02-24 |
20110045107 | Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines - A novel dietary supplement and nutritional aid and methods for the manufacture and administration of the same are disclosed for the efficacious treatment and/or prevention of digestive tract ulcers in horses and other animals. The dietary supplement of the present invention is effective in treating and/or preventing gastric ulcers, and in treating colonic ulcers as well. The dietary supplement of the present invention consists of safe and natural ingredients rather than drugs, and is orally administrable. The ingredients of the dietary supplement of the present invention when combined provide a synergistic efficacy which greatly exceeds the sum of the efficacies of the individual ingredients, making the dietary supplement highly effective in the treatment of digestive tract ulcers. | 2011-02-24 |
20110045108 | ANTI-DIABETIC EXTRACT OF HONEYBUSH - Novel and useful compositions derived from honeybush plant extract for treating diabetes are provided. It has been found that the plant extract of the present invention exhibit a superior antidiabetic effect when administered in an amount from about 1 milligram to about 5 milligrams, preferably to about 2.5 milligrams, per kilogram body weight. | 2011-02-24 |
20110045109 | NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING WHOLE-FRUIT ZANTHOXYLUM BUNGEANUM EXTRACT FOR COGNITION - The invention relates to a novel nutraceutical composition containing | 2011-02-24 |
20110045110 | Nutritional Compositions Containing Punicalagins - The present invention relates generally to a nutritional composition comprising punicalagins. | 2011-02-24 |
20110045111 | COMPOSITION COMPRISING THE EXTRACTS OF LINDERA OBTUSILOBA FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES - The present invention relates to a composition for treatment and prevention of cardiovascular diseases, containing an extract of | 2011-02-24 |
20110045112 | VARIABLE FOCUS OPHTHALMIC DEVICE - This invention discloses methods and apparatus for providing a variable optic insert into an ophthalmic lens. An energy source is capable of powering the variable optic insert included within the ophthalmic lens. In some embodiments, an ophthalmic lens is cast molded from a silicone hydrogel. | 2011-02-24 |
20110045113 | DIE CUSHION DEVICE - In the die cushion device, a shock absorber device relieves shock between a cushion pad and a support section. The shock absorber device includes a damping section and an elastic section. The damping section generates reaction force in accordance with the relative speed of the cushion pad with respect to the support section. The elastic section generates reaction force in accordance with the relative displacement of the cushion pad with respect to the support section. The controller section controls a servomotor so that a speed difference between the speed of the slide member and the speed of the support section is set to be a predetermined target speed difference value that changes over time. | 2011-02-24 |
20110045114 | CHOCOLATE MOLDING TRAY FOR A CHOCOLATE MANUFACTURING APPARATUS AND RELATED APPARATUS AND METHOD - A chocolate manufacturing machine includes a conveyor to advance a plurality of chocolate molding trays from a chocolate dispenser to a chocolate cooler downstream therefrom. The chocolate molding trays each have a face defining at least one chocolate mold cavity and have a back opposite the face. A plurality of face alignment features are associated with the face of each chocolate molding tray. Further, a plurality of back alignment features are associated with the back of each chocolate molding tray. The face and back alignment features permit alignment of an adjacent pair of chocolate molding trays in a face-to-face, back-to-back, and face-to-back relationship. The face and back alignment features may also permit vertical stacking and unstacking of adjacent pairs of the chocolate molding trays but limit horizontal movement thereof. | 2011-02-24 |
20110045115 | APPARATUS FOR TRANSFERRING OBJECTS - An apparatus for transferring objects includes a receiving arrangement, a transferring arrangement for transferring an object towards the receiving arrangement, the transferring arrangement having a recess for receiving the object, the recess being defined by a wall arrangement, and a driving arrangement arranged for moving at least part of the wall arrangement so as to change a passage section of the object through the recess. | 2011-02-24 |
20110045116 | APPARATUS FOR SEVERING AND COLLECTING IV TUBING TIPS - Mandrel supported IV tubing is inserted within a mold of a mold assembly to heat the IV tubing and form a tapered end of the tubing. The tip of the tubing extending beyond the tapered end of the tubing is severed by the mandrel bearing against the mold to lodge the tip in an outlet of the mold. Cooling air is introduced to the mold assembly to cool the mold and to create a flow of turbulent air about the outlet of the mold to extract the severed tips. The turbulent air is exhausted through a channel, pipe and fitting into a collection chamber and causes translation of the severed tip to and into the collection chamber. Sensors may be incorporated to sense the translation of the severed tips. | 2011-02-24 |
20110045117 | Method of preparing a molded article - A method of forming a shaped thermoplastic sheet includes providing a mold apparatus that includes, a first mold portion having an interior mold surface having a plurality of perforations and a perimeter edge. The mold apparatus further includes at least one sheet retainer having an upper surface having a plurality of perforations and a longitudinal axis that is oriented along at least a portion of the perimeter edge of the first mold portion. Each sheet retainer is reversibly and controllably: positionable along an x-, y- and/or z-axis relative to the perimeter edge; and rotatable around its longitudinal axis, toward and/or away from the perimeter edge. A heated thermoplastic sheet is formed and contacted (while at a thermoformable temperature) with the interior surface of the first mold portion and the exterior surfaces of the tubular sheet retainers. Reduced pressure is drawn through the perforations of the sheet retainers thereby retaining a portion of the heated thermoplastic sheet thereon. The sheet retainers are moved along the x-, y- and/or z-axes, and optionally rotated, with the sheet retained thereon, relative to the perimeter edge. Reduced pressure is drawn through the perforations of the interior mold surface, thereby drawing the heated thermoplastic sheet into intimate contour matching contact. The heated thermoplastic sheet is allowed to cool, and a shaped thermoplastic sheet retaining the contour of interior mold surface is formed. A sheet molding apparatus is also described. | 2011-02-24 |
20110045118 | Method of preparing a molded article - A method of preparing a molded article, and more particularly to a method of forming a shaped thermoplastic sheet. The method includes providing a mold apparatus that includes a first mold portion with a contoured and perforated interior mold surface, and a perimeter edge. The mold apparatus also includes a frame that surrounds at least a portion of the perimeter edge of the first mold portion. At least one sheet retainer resides on the upper surface of the frame. Each sheet retainer includes a clamp portion that faces towards the perimeter edge of the first mold portion, and which includes a reversibly closeable clamp member which defines in part a clamp interior. Each sheet retainer is independently, reversibly and laterally attached to the upper surface of the frame, such that each clamp portion is reversibly and laterally positionable relative to the perimeter edge of the first mold portion. In the method of the present invention, each sheet retainer, with a first portion of a heated thermoplastic sheet retained within the clamp portion thereof, is independently, reversibly and laterally moved towards and/or away from the perimeter edge of the first mold portion. Independent reversible and lateral positioning of each sheet retainer provides control over the thickness of the heated thermoplastic sheet that is contacted with the interior mold surface of the first mold portion during the molding process. Accordingly, such independent lateral positioning of each sheet retainer provides control over the thickness of various portions of the final molded article. | 2011-02-24 |
20110045119 | MOLD WITH EJECTION MECHANISM - An exemplary mold includes a core plate receiving a core insert, a cavity plate receiving a cavity insert, and an ejection mechanism for ejecting the core insert. The core insert defines a first molding surface, and the cavity insert defines a second molding surface cooperating with the first molding surface. The ejection mechanism includes a top plate, a bottom plate, and an ejection member fixed to the top plate. The ejection member includes an ejection rod and an ejection head. The ejection rod includes a first rod, and a first engaging body forming a protrusion facing toward the first rod. The ejection head includes a second rod, a second engaging body defining a recess facing toward the second rod, and an ejection portion engaged with the core insert. The protrusion is movably engaged in the recess, so that if the ejection rod goes off-axis, the core insert can stay on-axis. | 2011-02-24 |
20110045120 | RESIN INJECTION MOLD - Disclosed is a mold for resin injection molding that can realize rapid heating or cooling. A resin injection molding mold includes a cavity mold and a core mold and is produced on a base plate by metal photofabrication. The cavity mold is provided with a cavity warm water circuit for allowing warm water for heating to flow and a cavity cold water circuit for allowing cold water for cooling to flow. The core mold is also provided with a core warm water circuit and a core cold water circuit. The core mold includes an air blowing passage for feeding warm air or cold air into a resin molding part and a suction passage ( | 2011-02-24 |
20110045121 | LIGHT GUIDE PLATE INJECTION MOLDING DIE - A injection molding die includes a first molding unit, a second molding unit, at least one slide block, and a number of elastic elements disposed between the slide block and the first molding unit. The first molding unit includes a first molding surface and a sidewall surrounded the first molding surface. At least one gap is defined in an edge between the sidewall and the first molding surface. The gas hole is exposed at the gap for providing gas to the gap. The slide block is capable of moving toward or away from the sidewall, and includes a protrusion for engaging in the gap to cover the gas hole. The protrusion includes a protrusion surface coplanar with the first molding surface. The second molding unit includes a second mold surface defining a mold cavity cooperated with the first molding surface, the protrusion surface, and the at least one slide block. | 2011-02-24 |
20110045122 | DEVICE FOR DEMOULDING NEGATIVES IN PLASTIC INJECTION - The invention relates to a device for demoulding negatives in plastic injection, which is coupled to means for ejecting a plastic injection mould and includes a guide bushing that can be attached to the die plate of the movable part of the mould, inside which extends a counter-mould which moulds the negative and is formed by a guide runner and a head that can be lowered to demould the negative. The guide bushing contains a projection which pushes against the side of the head as the counter-mould moves forward, so that the head is lowered sideways and the negative is released. | 2011-02-24 |
20110045123 | Die for Injection Molding Glass with Frame - In an injection molding die, there is defined a cavity for a frame or a cavity for the frame and an auxiliary cavity communicating with the cavity for the frame, and into the cavity for the frame or the auxiliary cavity, there is injected a melted resin from a runner through a gate, and a section of the gate has a width of 1 to 5 mm in the direction of a thickness of a plate glass and a width of 10 mm or more in the direction parallel with a side of the plate glass but smaller than a side length of the plate glass. When this die is practically used, a load that would be applied to a peripheral portion of the plate glass during injection molding is reduced, so that when the frame is integrally molded to the plate glass by injection molding, undesired breakage of the plate glass is suppressed. | 2011-02-24 |
20110045124 | Injection Molding Nozzle Having A Nozzle Tip With Diamond Crown - An injection molding nozzle having improved corrosion and wear resistance is disclosed for use in a hot runner injection molding system. The nozzle includes a nozzle body having a nozzle melt channel for receiving a melt stream of moldable material from a melt source. The nozzle has a nozzle seal comprised of a tip retainer and a nozzle tip having a tip melt channel, wherein the tip retainer secures the nozzle tip to the nozzle body such that the tip melt channel receives the melt stream from the nozzle melt channel. The nozzle tip further includes a tip base of a thermally conductive material that has a diamond crown secured to a downstream end thereof. The diamond crown sits within a vestige area of the injection molding system and provides improved corrosion and wear resistance to the nozzle tip. | 2011-02-24 |
20110045125 | DRESSING COMPOSITION - A dressing composition comprising a fat phase, said fat phase comprising from 5 to 35% by weight pinolenic acid or a derivative thereof. There is also disclosed a process for preparing the dressing composition and the use of the dressing composition for a nutritional benefit. | 2011-02-24 |
20110045126 | DRESSING COMPOSITION - A dressing composition comprising a fat phase, said fat phase comprising at least 90% by weight conjugated linoleic acid or a derivative thereof (CLA). There is also disclosed a process for making the dressing composition, and also the use of the dressing composition for a nutritional benefit. | 2011-02-24 |
20110045127 | PLANTS WITH MODIFIED STARCH METABOLISM - The specification provides methods of obtaining a genetically modified plant which has increased production potential compared to a control plant, the method comprising the steps of i) obtaining a plurality of plants at least one of which comprises in its genome a heterologous polynucleotide, ii) identifying from the plurality of plants a plant which has increased production potential relative to the control plant and comprises the heterologous polynucleotide, and iii) selecting the genetically modified plant, wherein the polynucleotide comprises a transcriptional control sequence operably linked to a nucleic acid sequence which encodes an agent that modifies endogenous starch phosphorylation and/or starch degradation in the plant. In some embodiments, the plant has increased endogenous glycosylase or increased digestibility compared to a control plant. In some specific embodiments, the endogenous starch phosphorylation and/or starch degradation is modified by modifying expression or activity of one or more enzymes selected from the group consisting of α-amylase (EC 3.2.1.1), β-amylase (EC 3.2.1.2), glucoamylase (EC 3.2.1.3), starch phosphorylase (EC2.4.1.1), glycosylase (EC 3.1.33), sucrase-isomaltase (EC 3.2.10), amylomaltase (EC 2.4.1.25), maltase (EC 3.2.1.20), isoamylase, and α-glucan, water dikinase (GWD, EC 2.7.9.4). | 2011-02-24 |
20110045128 | PROCESS FOR REMOVING PHOSPHOLIPIDS AND OFF-FLAVORS FROM PROTEINS AND RESULTING PROTEIN PRODUCT - Described are methods of removing phospholipids and other off-flavor-causing compounds from edible proteins using a cyclodextrin treatment. The methods include treating soy protein with cyclodextrins such as β-cyclodextrin to form cyclodextrin-compound complexes and then separating the resulting complexes from the protein. Optionally, prior to treating the protein with cyclodextrin, the protein is sonicated and then treated with a phospholipase, such as phospholipase A | 2011-02-24 |
20110045129 | Plant Extracts as Additives for Yeast Raised Baked Goods - The present invention relates to the use of an active component for improving dough stability of yeast dough, for making baked goods, and/or for improving the volume of yeast raised baked goods, wherein the active component comprises a member selected from the group consisting of an extract of any part of a plant of the species | 2011-02-24 |